Investor Insight Radiopharm Theranostics represents a promising investment opportunity in the rapidly growing field of radiopharmaceuticals, leveraging its innovative technology platform and diverse clinical pipeline. Overview Radiopharm Theranostics (ASX:RAD) is an innovative biopharmaceutical company specializing in the development of radiopharmaceutical products for both diagnostic and therapeutic applications. Founded with a…
China’s Zijin Mining Group (OTC Pink:ZIJMF,SHA:601899) is reportedly in negotiations to acquire a potential controlling interest in Zangge Mining…
Cybercrime is a growing concern, and it’s estimated that the annual cost of fighting cyber crime will reach US$10.5…
Micron Technology (NASDAQ:MU) announced a US$7 billion investment to build a high-bandwidth memory (HBM) chip-packaging facility in Singapore to…
Iron prices started off strong at the beginning of 2024, but have since dropped steeply to two-year lows. Market…
The nickel market has faced challenges over the past few years due to a supply glut and weak demand.…
From established players to up-and-coming firms, Canada’s pharmaceutical company landscape is diverse and dynamic. Canadian drug companies are working…
Cobalt prices started 2024 trading at the US$29,151.50 per metric ton level, the highest price point the battery metal…
Lead prices rode a wave of volatility in 2024 as global economic uncertainty continued to wreak havoc on metals…